U.S. Biotech Stock News

NYSE:NVO
NYSE:NVOPharmaceuticals

Is Novo Nordisk (NYSE:NVO) Now Attractive After Recent Share Price Weakness?

If you are wondering whether Novo Nordisk’s current share price offers value or carries more risk than reward, it starts with understanding how the market is now treating this long established pharmaceutical name. The stock last closed at US$36.40, with returns of a 1.8% decline over 7 days, 5.7% decline over 30 days, 30.5% decline year to date, 47.1% decline over 1 year, and 52.5% decline over 3 years, while the 5 year return sits at 13.2%. These moves have come as attention around Novo...
NYSE:MAS
NYSE:MASBuilding

Masco (MAS) Valuation Check After FTSE All World Index Removal And Recent Selling Pressure

Index removal puts Masco in focus Masco (MAS) was recently removed from the FTSE All-World Index (USD). This type of event can prompt mechanical selling by index-tracking funds and bring short term trading pressures onto the stock. See our latest analysis for Masco. At a share price of US$60.19, Masco has had a 1 month share price return of 18.53% decline and a 1 year total shareholder return of 12.96% decline. However, the 3 year total shareholder return of 31.17% suggests longer term...
NYSE:LMT
NYSE:LMTAerospace & Defense

Lockheed Martin’s Golden Dome Role And Space Electronics Shift Under Review

Lockheed Martin (NYSE:LMT) is part of a consortium selected by the Pentagon to provide software for the new "Golden Dome" missile defense integration program, valued at about US$185b. The company is working alongside defense software and AI players, including Palantir and Anduril, within this multi decade effort to unify missile defense systems. Terran Orbital, in which Lockheed Martin has a key role, is expanding its space and defense electronics offering with a new star tracker product...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

ADMA Biologics Challenges Short Report As Valuation And Compliance Scrutinized

ADMA Biologics (NasdaqGM:ADMA) issued a public response to a short-seller report from Culper Research. The company disputed the accuracy of the allegations and reiterated its focus on regulatory compliance. This exchange centers on claims about ADMA Biologics' business practices and disclosures. For investors, this is notable because ADMA Biologics operates in a tightly regulated biopharmaceutical space where compliance is central to its plasma based therapies business. When a short-seller...
NasdaqGM:GDS
NasdaqGM:GDSIT

GDS Holdings (NasdaqGM:GDS) Valuation After Earnings Show Revenue Growth But Weaker Profitability And 2026 Outlook

Earnings results and 2026 outlook draw fresh focus to GDS Holdings GDS Holdings (GDS) is back in the spotlight after reporting fourth quarter and full year 2025 results that combined higher revenue with sharply weaker profitability, along with 2026 revenue guidance pointing to further top line expansion. See our latest analysis for GDS Holdings. The share price reaction to the latest earnings and 2026 guidance has been negative in the short term, with a 1 day share price return of a 6.69%...
NasdaqGS:ACLX
NasdaqGS:ACLXBiotechs

Is It Too Late To Consider Arcellx (ACLX) After Its Strong 81% YTD Rally?

Wondering if Arcellx at around US$114 per share still offers value, or if the easy money has already been made. The stock has YTD returns of 81.0% and a 1 year return of 68.7%, although the past week has been flat at around a 0.1% decline and the 30 day move sits at 0.8%. Recent coverage has focused on Arcellx as a higher growth biotech name, which helps explain why the share price has been so strong over the past year. That kind of attention often shifts how investors think about both the...
NasdaqGS:CG
NasdaqGS:CGCapital Markets

A Look At Carlyle Group (CG) Valuation After Recent Share Price Weakness

Why Carlyle Group Stock Is On Investors’ Radar Carlyle Group (CG) has drawn fresh attention after a period of weaker share performance, with the stock declining about 8% over the past month and roughly 23% over the past 3 months. At a last close of US$46.77, the firm carries a market value of about US$16.98b, supported by reported revenue of US$4,031.6m and net income of US$808.7m across its global investment platform. See our latest analysis for Carlyle Group. The recent 1 month share price...
NYSE:UTI
NYSE:UTIConsumer Services

Is It Too Late To Consider Universal Technical Institute (UTI) After Its Strong Share Price Run?

Wondering if Universal Technical Institute at US$37.96 is priced for its past, its future, or a bit of both? This article focuses squarely on what that share price could mean for value minded investors. The stock has logged returns of 1.7% over 7 days, 9.4% over 30 days, 52.8% year to date, and 43.2% over the last year, which naturally raises questions about what expectations are now built into the current price. Recent attention on Universal Technical Institute has centered on its share...
NYSE:ARLO
NYSE:ARLOElectronic

The Bull Case For Arlo Technologies (ARLO) Could Change Following Upside Revenue Surprise And Profitability Inflection – Learn Why

Arlo Technologies recently reported a past quarter in which revenue grew 16.2% year on year, beating analyst forecasts by 4.2% and delivering earnings per share above expectations for both the reported period and its next-quarter guidance. The company also moved from negative to positive full-year earnings per share over the last five years, highlighting a key profitability inflection that builds on its 8.2% annualized revenue growth in the same period. Next, we will examine how Arlo’s...
NYSE:HAL
NYSE:HALEnergy Services

Halliburton (HAL) Valuation Check As Shares Deliver Strong 1 Year Return

Halliburton stock snapshot Halliburton (HAL) is back in focus for investors as its recent share performance, revenue mix, and profitability metrics draw attention to how this large oilfield services group is currently priced in the market. See our latest analysis for Halliburton. At a share price of $38.79, Halliburton has seen momentum build, with a 30 day share price return of 8.38% and a 1 year total shareholder return of 57.27%, which reflects changing sentiment over time. If you are...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Did Nasdaq's (NDAQ) Talos Deal Quietly Reframe Its AI and Digital Infrastructure Ambitions?

Earlier this week, Nasdaq and Talos announced a partnership to link Talos’ digital asset infrastructure with Nasdaq’s Calypso and Trade Surveillance platforms, creating an integrated solution for managing tokenized collateral and monitoring digital asset trading activity. This collaboration directly targets operational and compliance hurdles that have limited institutional use of tokenized collateral, aiming to bring on- and off-chain assets under the same risk, collateral, and surveillance...
NasdaqGS:NCNO
NasdaqGS:NCNOSoftware

How Mortgage Automation Gains and Luana Savings Bank Win May Shape nCino’s (NCNO) Investment Narrative

Earlier this month, nCino launched nCino Doc VOI powered by Argyle to automate income verification within its Mortgage Solution, and Luana Savings Bank selected nCino’s Commercial and Agricultural Lending Solutions to modernize and unify its lending operations. Together, the new mortgage automation feature and the Luana Savings Bank win highlight how nCino is embedding deeper into lenders’ workflows across both retail mortgage and commercial/agricultural lending. We’ll now assess how the...
NasdaqCM:NESR
NasdaqCM:NESREnergy Services

New US$300m Cementing Contracts Test NESR Valuation And Profitability

National Energy Services Reunited secured cementing contracts worth about $300 million across Kuwait and North Africa. The agreements extend over roughly five years and support the company’s position in the MENA oilfield services market. The new work adds to project backlog and revenue visibility that had not been highlighted in recent coverage. National Energy Services Reunited, traded as NasdaqCM:NESR, now has fresh multi year cementing work that directly ties into its core operations in...
NasdaqGS:GLDD
NasdaqGS:GLDDConstruction

Is It Too Late To Consider Great Lakes Dredge & Dock (GLDD) After 1‑Year 88% Gain?

Wondering if Great Lakes Dredge & Dock at around US$16.97 is still offering value, or if most of the opportunity is already priced in. The share price has been relatively steady in the very short term, with returns of 0.1% over 7 days and 0.2% over 30 days, while the longer term picture shows returns of 28.0% year to date and 88.8% over 1 year. Over a 3 year period, the stock has returned 220.8%, compared with 13.1% over 5 years. This gives useful context for how sentiment around the...
NasdaqGS:VNOM
NasdaqGS:VNOMOil and Gas

Assessing Viper Energy (VNOM) Valuation After Recent Share Price Strength

Fresh move in Viper Energy stock Viper Energy (VNOM) has drawn investor attention after a recent share price move, with the stock closing at US$47.82 and showing positive returns over the past month and past 3 months. See our latest analysis for Viper Energy. The recent 30 day share price return of 5.12% builds on a strong 90 day share price return of 25.48%. The 1 year total shareholder return of 13.73% points to steadier, longer term progress. If Viper Energy's move has you looking beyond a...
NYSE:TJX
NYSE:TJXSpecialty Retail

Assessing TJX Companies (TJX) Valuation After Recent Steady Share Price Performance

Why TJX Companies (TJX) Is On Investor Radars Today TJX Companies (TJX) is in focus after recent share price moves, with the stock posting a small 1 day decline and modest gains over the past week and over the past 3 months. See our latest analysis for TJX Companies. That small 1 day share price pullback to US$157.57 comes after a steady period where the 1 year total shareholder return is 32.28% and the 5 year total shareholder return is 156.94%. This suggests recent momentum builds on longer...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

Assessing NetApp (NTAP) Valuation After New Cyber Resilience And AI Data Engine Launches

Recent announcements from NetApp (NTAP) around ransomware resilience partnerships with Elastio and Commvault, next generation EF Series storage, and the upcoming AI Data Engine with NVIDIA provide additional context for assessing the stock. See our latest analysis for NetApp. Despite the recent product and cyber resilience announcements, the share price has been relatively steady, with a 30-day share price return of 4.59% and a 1-year total shareholder return of 17.04%. This suggests moderate...
NYSE:NOMD
NYSE:NOMDFood

A Look At Nomad Foods (NOMD) Valuation After BTIG Target Cut And CEO Share Purchase Plan

Nomad Foods (NOMD) is back on investor radars after BTIG maintained its positive rating and cut its price target following weaker Q4 results, as the CEO pledged a sizeable open market share purchase. See our latest analysis for Nomad Foods. At a share price of US$9.70, Nomad Foods has seen a 1 day share price return of 1.04%, but a 30 day share price return decline of 25.15% and a 1 year total shareholder return decline of 48.42%, which signals fading momentum despite management’s recent Q4...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

Assessing 10x Genomics (TXG) Valuation After STELA Partnership And Ongoing Cathie Wood Buying

Why 10x Genomics Is Back in Focus 10x Genomics (TXG) is back on investor watchlists after two catalysts: its role in Bioptimus’ new STELA spatial tissue atlas, and steady share purchases by high profile fund manager Cathie Wood. See our latest analysis for 10x Genomics. The recent partnership on the STELA initiative and continued buying from Cathie Wood have arrived while the share price sits at US$20.43, with a 90 day share price return of 23.89% and a 1 year total shareholder return of...